Two Novel Β-Thalassemia Gene Mutations Were Detected in Chinese Patients: CD13/14(-C) and Beta Nt1582(a>g), PolyA(AATAAA>GATAAA)

Xiao-ying PAN,Bin TANG,Ju-qing LIANG,Hong-yi GAO,Ai-hua YIN,Jing WU,Ji-cheng WANG,Yan-fang ZHONG,Wei-jie ZHU
2009-01-01
Abstract:Objective: To identify two novel β-thalassemia gene mutations in Chinese patients: CD13/14 (-C) and beta nt1582 (A>G), PolyA (AATAAA>GATAAA). Methods: Ten suspected cases were selected in the prenatal diagnosis center for further diagnosing β-thalassemia. Among them, 7 cases were suspected as β-thalassemia trait, 1 case was suspected as β-thalassemia major, and 2 cases were fetus whose parents were β-thalassemia gene carriers. The samples were determined by using polymerase chain reaction and reverse dot blot hybridization (PCR-RDB) techniques, and β-hemoglobin direct genomic sequencing (DGS). Results: Two types of common β-thalassemia gene mutations were detected with PCR-RDB in 3 patients and 1 fetus, which were IVS-2-654 (C>T) and-28 (A>G). Five types of rare β-thalassemia gene mutations were detected with DGS in 6 patients and 1 fetus. Among these 5 rare gene mutations, 2 novel gene mutations had been found, which were beta nt 1582 (A>G), PolyA(AATAAA>GATAAA) and CD 13/14(-C). Conclusion: Two novel β-thalassemia gene muta-tions were detected, which phenotype would be β+ or β0. If a suspected case couldn't be identified by PCR-RDB, DNA sequencing should be used for further investigation.
What problem does this paper attempt to address?